Search Results - "Srivastava, B.S."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Synthesis and antimycobacterial activities of glycosylated amino alcohols and amines by Katiyar, D., Tiwari, V.K., Tewari, N., Verma, S.S., Sinha, S., Gaikwad, A., Srivastava, A., Chaturvedi, V., Srivastava, R., Srivastava, B.S., Tripathi, R.P.

    Published in European journal of medicinal chemistry (01-04-2005)
    “…Reduction of glycosyl β-amino esters ( 6– 14 and 25– 30) with lithium aluminum hydride resulted in glycosyl amino alcohols ( 15– 23 and 31– 36) in good yields…”
    Get full text
    Journal Article
  2. 2

    Synthesis and bioevaluation of glycosyl ureas as α-glucosidase inhibitors and their effect on mycobacterium by TEWARI, Neetu, TIWARI, V. K, MISHRA, R. C, TRIPATHI, R. P, SRIVASTAVA, A. K, AHMAD, R, SRIVASTAVA, R, SRIVASTAVA, B. S

    Published in Bioorganic & medicinal chemistry (03-07-2003)
    “…Glycosyl amino esters (2-13) on reaction with different isocyanates resulted in quantitative conversion to glycosyl ureas (14--32). Few of the selected ureas…”
    Get full text
    Journal Article
  3. 3

    Synthesis of glycosylated β-amino acids as new class of antitubercular agents by Tripathi, R.P., Tripathi, R., Tiwari, V.K., Bala, Laxmi, Sinha, S, Srivastava, A., Srivastava, R., Srivastava, B.S.

    Published in European journal of medicinal chemistry (01-09-2002)
    “…A series of glycosylated β-amino acids was prepared and evaluated against Mycobacterium tuberculosis, M. avium, M. fortuitum and M. smegmatis. The compounds…”
    Get full text
    Journal Article
  4. 4

    Synthesis and antimycobacterial activity of 3,5-disubstituted thiadiazine thiones by Katiyar, D., Tiwari, V.K., Tripathi, R.P., Srivastava, A., Chaturvedi, V., Srivastava, R., Srivastava, B.S.

    Published in Bioorganic & medicinal chemistry (01-10-2003)
    “…A series of 3,5-disubstituted thiadiazine thiones ( 4– 24) have been synthesized by reaction of primary amines with carbon disulphide followed by…”
    Get full text
    Journal Article
  5. 5

    Synthesis and antitubercular activities of bis-glycosylated diamino alcohols by Tripathi, R.P., Tiwari, V.K., Tewari, N., Katiyar, D., Saxena, N., Sinha, S., Gaikwad, A., Srivastava, A., Chaturvedi, V., Manju, Y.K., Srivastava, R., Srivastava, B.S.

    Published in Bioorganic & medicinal chemistry (01-10-2005)
    “…A number of bis-glycosylated diamino-alcohols were synthesized and evaluated against M. tuberculosis, and many of them were found to have good in vitro…”
    Get full text
    Journal Article
  6. 6

    Vibrio cholerae persistence in aquatic environments and colonization of intestinal cells: involvement of a common adhesion mechanism by Zampini, Massimiliano, Pruzzo, Carla, Bondre, Vijay P., Tarsi, Renato, Cosmo, Mariangela, Bacciaglia, Alessandro, Chhabra, Arvind, Srivastava, Renjana, Srivastava, Brahm S.

    Published in FEMS microbiology letters (15-03-2005)
    “…Forty-one Tn pho A mutants of Vibrio cholerae O1 classical strain CD81 were analyzed for their ability to interact with chitin particles, Tigriopus fulvus…”
    Get full text
    Journal Article
  7. 7

    Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents by Tewari, Neetu, Tiwari, V.K., Tripathi, R.P., Chaturvedi, V., Srivastava, A., Srivastava, R., Shukla, P.K., Chaturvedi, A.K., Gaikwad, A., Sinha, S., Srivastava, B.S.

    Published in Bioorganic & medicinal chemistry letters (19-01-2004)
    “…The galactopyranosyl amino alcohols ( 3– 16) were synthesised by regioselective oxirane ring opening of compound 2 with variety of amines and screened for…”
    Get full text
    Journal Article
  8. 8

    Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach by Deb, D.K., Dahiya, P., Srivastava, K.K., Srivastava, R., Srivastava, B.S.

    Published in Tuberculosis (Edinburgh, Scotland) (01-01-2002)
    “…The in vivo induced antigen technology (IVIAT) 1 has been used for the identification of open reading frames (ORFs) which could be possible therapeutic…”
    Get full text
    Journal Article
  9. 9

    Bioluminescent Mycobacterium aurum Expressing Firefly Luciferase for Rapid and High Throughput Screening of Antimycobacterial Drugs in Vitro and in Infected Macrophages by Deb, D.K., Srivastava, K.K., Srivastava, Ranjana, Srivastava, B.S.

    “…The slow growth and highly infectious nature of Mycobacterium tuberculosis is a limiting factor in its use as test organism in high throughput screening for…”
    Get full text
    Journal Article
  10. 10

    Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: An observation with Escherichia coli β-galactosidase in Mycobacterium smegmatis and its implication in vaccine development by Kumar, Deepak, Srivastava, B.S., Srivastava, Ranjana

    Published in Vaccine (01-07-1998)
    “…Different mycobacteria carrying cloned genes for heterologous protective antigens have been proposed as vaccine vehicles. In this study, the stability of the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Protective antigens of Mycobacterium habana are distributed between peripheral and integral compartments of plasma membrane: a study in experimental tuberculosis of mouse by Chaturvedi, Vinita, Srivastava, Anil, Gupta, H.P, Srivastava, B.S

    Published in Vaccine (16-07-1999)
    “…Mycobacterium habana, a cultivable nonpathogenic mycobacterium provides appreciable resistance in mouse against M. tuberculosis infection. This study is aimed…”
    Get full text
    Journal Article
  13. 13
  14. 14